Our Managing Director, Mo Alavijeh, is heading up to bonnie Scotland for ELRIG's "Drug Discovery in Scotland Forum"
September 11, 2024
Mo is looking forward to networking with fellow drug discovery professionals.
Say "Hello!" if you see him. Connect on
LinkedIn, or send us an email at
[email protected], if you're interested in finding out more about the preclinical services offers to support your drug discovery programmes.
#Pharmidex #drugdiscovery #preclinical #GLP #GCP #networking #meeting #drugdevelopment #edinburgh #collaboration #cro #contractresearchorganisation #toxicology #respiratory #CNS #oncology #DMPK #bioanalysis #insilico #autoimmunediseases
We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. 👩🔬 👨🔬 Welcome to the team, Gabrielle and Mohammed!
At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: ✅ Bitter-tasting APIs ✅ Unpalatable excipients ✅ The success of taste-masking strategies ✅ Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.
